UBS Group’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Sell |
242,090
-601,103
| -71% | -$3.26M | ﹤0.01% | 4147 |
|
|
2025
Q1 | $2.34M | Buy |
843,193
+266,296
| +46% | +$738K | ﹤0.01% | 3594 |
|
|
2024
Q4 | $1.97M | Buy |
576,897
+517,223
| +867% | +$1.76M | ﹤0.01% | 3724 |
|
|
2024
Q3 | $175K | Sell |
59,674
-53,298
| -47% | -$157K | ﹤0.01% | 4794 |
|
|
2024
Q2 | $384K | Sell |
112,972
-591,219
| -84% | -$2.01M | ﹤0.01% | 4111 |
|
|
2024
Q1 | $2.13M | Buy |
704,191
+572,319
| +434% | +$1.73M | ﹤0.01% | 2922 |
|
|
2023
Q4 | $555K | Buy |
131,872
+56,316
| +75% | +$237K | ﹤0.01% | 3899 |
|
|
2023
Q3 | $516K | Sell |
75,556
-13,200
| -15% | -$90.2K | ﹤0.01% | 3577 |
|
|
2023
Q2 | $925K | Sell |
88,756
-79,512
| -47% | -$829K | ﹤0.01% | 3377 |
|
|
2023
Q1 | $1.17M | Buy |
168,268
+81,964
| +95% | +$571K | ﹤0.01% | 3060 |
|
|
2022
Q4 | $520K | Buy |
86,304
+26,103
| +43% | +$157K | ﹤0.01% | 3658 |
|
|
2022
Q3 | $475K | Buy |
60,201
+30,525
| +103% | +$241K | ﹤0.01% | 3411 |
|
|
2022
Q2 | $403K | Buy |
29,676
+24,383
| +461% | +$331K | ﹤0.01% | 3480 |
|
|
2022
Q1 | $104K | Buy |
5,293
+103
| +2% | +$2.02K | ﹤0.01% | 4883 |
|
|
2021
Q4 | $178K | Buy |
5,190
+1,646
| +46% | +$56.5K | ﹤0.01% | 4748 |
|
|
2021
Q3 | $193K | Sell |
3,544
-110,087
| -97% | -$6M | ﹤0.01% | 4303 |
|
|
2021
Q2 | $8.35M | Buy |
113,631
+109,646
| +2,751% | +$8.06M | ﹤0.01% | 1634 |
|
|
2021
Q1 | $364K | Buy |
3,985
+424
| +12% | +$38.7K | ﹤0.01% | 4138 |
|
|
2020
Q4 | $288K | Buy |
3,561
+2,346
| +193% | +$190K | ﹤0.01% | 4042 |
|
|
2020
Q3 | $57K | Buy |
+1,215
| New | +$57K | ﹤0.01% | 4702 |
|